Cart
sales@molnova.com
2-Aminoacetophenone
CAS No. 551-93-9
2-Aminoacetophenone( —— )
Catalog No. M32718 CAS No. 551-93-9
Compound Fr14273 is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 32 | In Stock |
|
| 1G | 47 | In Stock |
|
Biological Information
-
Product Name2-Aminoacetophenone
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompound Fr14273 is a natural product for research related to life sciences.
-
Description2'-Aminoacetophenone is an aromatic compound containing a ketone substituted by one alkyl group, and a phenyl group. 2'-Aminoacetophenone can be used as a breath biomarker for the detection of Ps. Aeruginosa infections in the cystic fibrosis lung.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number551-93-9
-
Formula Weight135.17
-
Molecular FormulaC8H9NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (739.86 mM; Ultrasonic )
-
SMILESCC(=O)C1=C(N)C=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Amy J Scott-Thomas?, et al. 2-Aminoacetophenone as a Potential Breath Biomarker for Pseudomonas Aeruginosa in the Cystic Fibrosis Lung. BMC Pulm Med.?2010 Nov 7;10:56.?
molnova catalog
related products
-
1-{1H-pyrrolo[2,3-d]...
1-{1H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine dihydrochloride is a compound used as a molecular building block.
-
Exendin-3
Exendin-3 is a biologically active peptides isolated from venoms of the Gila monster lizards, Heloderma horridurn . Exendin-3 is a pancreatic secretagogue, which is a member of the glucagon family. It is found in the venom of Heloderma horridurn, which is a Gila monster lizard.
-
D(-)-Arabinose
Arabinose is an aldopentose – a monosaccharide containing five carbon atoms, and including an aldehyde (CHO) functional group.
